secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shattuck Labs, Inc. (STTK)
CIK:        0001680367
Form:       8-K
Filed at:   2021-10-28T23:59:59+00:00
Accession:  0001193125-21-311373
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shattuck Labs appoints Dr. Carrie Brownstein to board; George Golumbeski named Chairman
--------------------------------------------------------------------------------

- Josiah Hornblower resigned as director and Chairman effective October 22, 2021; no dispute with company.
- Independent director George Golumbeski appointed Chairman of the Board.
- Dr. Carrie Brownstein, CMO of Cellectis, appointed as Class I director and to Nominating and Corporate Governance Committee.
- Brownstein brings over 15 years of oncology/rare disease drug development experience from Roche, Regeneron, Celgene.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680367/000119312521311373/0001193125-21-311373-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680367/000119312521311373/d245532d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-311373

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer